SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001204459-11-001551
Filing Date
2011-05-31
Accepted
2011-05-31 15:16:52
Documents
17
Period of Report
2011-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 40-F form40f.htm 40-F 23406
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 292479
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 837512
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 4850
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 125160
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 221607
7 EXHIBIT 99.6 exhibit99-6.htm EX-99.6 2690
8 EXHIBIT 99.7 exhibit99-7.htm EX-99.7 13805
9 EXHIBIT 99.8 exhibit99-8.htm EX-99.8 3742
10 mdnax1x1.jpg GRAPHIC 5713
11 aifht1.jpg GRAPHIC 12236
12 aifht2.gif GRAPHIC 12976
13 exhibit99-3x1x1.jpg GRAPHIC 1955
14 exhibit99-6x1x1.jpg GRAPHIC 1908
15 form401.jpg GRAPHIC 2914
16 form402.gif GRAPHIC 1565
17 form403.gif GRAPHIC 2658
  Complete submission text file 0001204459-11-001551.txt   1585038
Mailing Address 225 PROMENADE DU CENTROPOLIS SUITE 200 LAVAL A8 H7T 0B3
Business Address 225 PROMENADE DU CENTROPOLIS SUITE 200 LAVAL A8 H7T 0B3 (450) 687-2262
Neptune Technologies & Bioressources Inc. (Filer) CIK: 0001401395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 40-F | Act: 34 | File No.: 001-33526 | Film No.: 11881141
SIC: 2834 Pharmaceutical Preparations